1. Home
  2. DMRA vs PEB Comparison

DMRA vs PEB Comparison

Compare DMRA & PEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DMRA

Damora Therapeutics Inc. Common Stock

N/A

Current Price

$21.40

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Logo Pebblebrook Hotel Trust of Beneficial Interest

PEB

Pebblebrook Hotel Trust of Beneficial Interest

HOLD

Current Price

$17.00

Market Cap

1.7B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
DMRA
PEB
Founded
2011
2009
Country
United States
United States
Employees
7
52
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
DMRA
PEB
Price
$21.40
$17.00
Analyst Decision
Buy
Hold
Analyst Count
2
11
Target Price
$43.00
$13.30
AVG Volume (30 Days)
356.8K
1.7M
Earning Date
05-11-2026
04-28-2026
Dividend Yield
N/A
0.28%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.25
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.50
$8.88
52 Week High
$28.76
$16.88

Technical Indicators

Market Signals
Indicator
DMRA
PEB
Relative Strength Index (RSI) 31.88 79.68
Support Level $16.50 $13.77
Resistance Level $26.66 N/A
Average True Range (ATR) 1.61 0.45
MACD -0.37 0.18
Stochastic Oscillator 13.54 96.29

Price Performance

Historical Comparison
DMRA
PEB

About DMRA Damora Therapeutics Inc. Common Stock

Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.

About PEB Pebblebrook Hotel Trust of Beneficial Interest

Pebblebrook Hotel Trust currently owns upper upscale and luxury hotels with 11,052 rooms across 44 hotels in the United States. Pebblebrook acquired LaSalle Hotel Properties, which owned 10,451 rooms across 41 US hotels, in November 2018, though management has sold many of those hotels over the past few years. Pebblebrook's portfolio consists mostly of independent hotels with no brand affiliations, though the combined company does own and operate some hotels under Marriott, Starwood, InterContinental, Hilton, and Hyatt brands.

Share on Social Networks: